New Delhi, Sept. 25 -- For the first time, scientists have found a way to dramatically slow Huntington's disease, an inherited brain disorder that has long been considered untreatable. A groundbreaking gene therapy called AMT-130 has shown promising results in clinical trials, slowing disease progression by up to 75 percent. Huntington's disease slowly damages nerve cells in the brain, leading to problems with movement, memory, and independence. Until now, patients could only rely on treatments that managed symptoms, not the disease itself. But new research is showing that things may be changing. With gene therapy, patients could experience a much slower decline and enjoy more years of good quality life, giving families a reason to feel h...